Skip to main content
Year archive

Genix Pharmaceuticals Corporation — 2023 filings

All 20 regulatory filings released by Genix Pharmaceuticals Corporation (GENX) in 2023, sourced directly from the official regulator.

20 Filings
2023 Period
2023 filings (20)
Filing Released Lang
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-09-26 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-09-26 English
Interim MD&A - English.pdf
Interim / Quarterly Report 9M 2023
2023-09-26 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report 9M 2023
2023-09-26 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-06-27 English
Interim MD&A - English.pdf
Regulatory Filings
2023-06-27 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-06-27 English
News release - English.pdf
Regulatory Filings
2023-05-26 English
Form of proxy - English.pdf
Regulatory Filings
2023-04-25 English
Other.pdf
Regulatory Filings
2023-03-29 English
Notice of the meeting and record date - English.pdf
AGM Information
2023-03-23 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-03-23 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-03-23 English
Interim MD&A - English.pdf
Interim / Quarterly Report Q1 2023
2023-03-23 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Q1 2023
2023-03-23 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2023-03-01 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-03-01 English
Annual MD&A - English.pdf
Regulatory Filings
2023-03-01 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-03-01 English
Audited annual financial statements – English.pdf
Regulatory Filings
2023-03-01 English